Tower Research Capital LLC (Trc) Rani Therapeutics Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,721 shares of RANI stock, worth $3,906. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,721
Previous 14,437
88.08%
Holding current value
$3,906
Previous $54,000
94.44%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RANI
# of Institutions
36Shares Held
5.78MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$5.84 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$1.61 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$1.12 Million1.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$1.02 Million0.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$687,2260.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $55.6M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...